Stress hormone-mediated invasion of ovarian cancer cells

被引:399
作者
Sood, AK
Bhatty, R
Kamat, AA
Landen, CN
Han, L
Thaker, PH
Li, Y
Gershenson, DM
Lutgendorf, S
Cole, SW
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77230 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77230 USA
[3] Univ Iowa, Coll Med, Iowa City, IA USA
[4] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA
[5] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA
关键词
D O I
10.1158/1078-0432.CCR-05-1698
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: There is growing evidence that stress and other behavioral factors may affect cancer progression and patient survival. The underlying mechanisms for this association are poorly understood. The purpose of this study is to determine the effects of stress-associated hormones norepinephrine, epinephrine, and cortisol on the invasive potential of ovarian cancer cells. Experimental Design:The ovarian cancer cells EG, SKOV3, and 222 were exposed to increasing levels of either norepinephrine, epinephrine, or cortisol, and the in vitro invasive potential was determined using the membrane invasion culture system. Additionally, the effects of these stress hormones on matrix metalloproteinase-2 (MMP-2) and MMP-9 were determined by ELISA. The effects of the beta-adrenergic agonist isoproterenol on in vivo tumor growth were determined using nude mice. Results: Stress levels of norepinephrine increased the in vitro invasiveness of ovarian cancer cells by 89% to 198%. Epinephrine also induced significant increases in invasion in all three cell lines ranging from 64% to 76%. Cortisol did not significantly affect invasiveness of the EG and 222 cell lines but increased invasion in the SKOV3 cell line (P = 0.01). We have previously shown that ovarian cancer cells express beta-adrenergic receptors. The beta-adrenergic antagonist propanolol (1 mu mol/L) completely blocked the norepinephrine-induced increase in invasiveness. Norepinephrine also increased tumor cell expression of MMP-2 (P = 0.02 for both SKOV3 and EG cells) and MMP-9 (P = 0.01 and 0.04, respectively), and pharmacologic blockade of MMPs abrogated the effects of norepinephrine on tumor cell invasive potential. Isoproterenol treatment resulted in a significant increase in tumor volume and infiltration in the SK0V3ip1 in vivo model, which was blocked by propranolol. Conclusions: These findings provide direct experimental evidence that stress hormones can enhance the invasive potential of ovarian cancer cells. These effects are most likely mediated by stimulation of MMPs.
引用
收藏
页码:369 / 375
页数:7
相关论文
共 66 条
  • [31] ADRENERGIC REGULATION OF OVARIAN ANDROGEN BIOSYNTHESIS IS MEDIATED VIA BETA-ADRENERGIC THECA-INTERSTITIAL CELL RECOGNITION SITES
    HERNANDEZ, ER
    JIMENEZ, JL
    PAYNE, DW
    ADASHI, EY
    [J]. ENDOCRINOLOGY, 1988, 122 (04) : 1592 - 1602
  • [32] Huang SY, 2002, J NATL CANCER I, V94, P1134
  • [33] Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palade bodies in human endothelial cells both in vitro and in vivo
    Huber, D
    Cramer, EM
    Kaufmann, JE
    Meda, P
    Massé, JM
    Kruithof, EKO
    Vischer, UM
    [J]. BLOOD, 2002, 99 (10) : 3637 - 3645
  • [34] Joseph J, 2002, CANCER RES, V62, P6467
  • [35] Matrix metalloproteinases and metastasis
    Kleiner, DE
    Stetler-Stevenson, WG
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (Suppl 1) : S42 - S51
  • [36] INVOLVEMENT OF NERVE GROWTH-FACTOR IN FEMALE SEXUAL DEVELOPMENT
    LARA, HE
    MCDONALD, JK
    OJEDA, SR
    [J]. ENDOCRINOLOGY, 1990, 126 (01) : 364 - 375
  • [37] Changes in sympathetic nerve activity of the mammalian ovary during a normal estrous cycle and in polycystic ovary syndrome:: Studies on norepinephrine release
    Lara, HE
    Dorfman, M
    Venegas, M
    Luza, SM
    Luna, SL
    Mayerhofer, A
    Guimaraes, MA
    Silva, AAMRE
    Ramírez, VD
    [J]. MICROSCOPY RESEARCH AND TECHNIQUE, 2002, 59 (06) : 495 - 502
  • [38] Release of norepinephrine from human ovary - Coupling to steroidogenic response
    Lara, HE
    Porcile, A
    Espinoza, J
    Romero, C
    Luza, SM
    Fuhrer, J
    Miranda, C
    Roblero, L
    [J]. ENDOCRINE, 2001, 15 (02) : 187 - 192
  • [39] IMMUNOLOGICAL AND PSYCHOSOCIAL PREDICTORS OF DISEASE RECURRENCE IN PATIENTS WITH EARLY-STAGE BREAST-CANCER
    LEVY, SM
    HERBERMAN, RB
    LIPPMAN, M
    DANGELO, T
    LEE, J
    [J]. BEHAVIORAL MEDICINE, 1991, 17 (02) : 67 - 75
  • [40] The microenvironment of the tumour-host interface
    Liotta, LA
    Kohn, EC
    [J]. NATURE, 2001, 411 (6835) : 375 - 379